Biotechnology

Regen BioPharma, Inc.

Regen BioPharma, Inc. released FY2025 Q4 earnings on December 30 (EST), actual revenue USD 59.37 K, actual EPS USD -0.0173

Regen BioPharma, Inc. released FY2025 annual earnings on December 30, 2025 (EST) with actual revenue of USD 236.56 K and EPS of USD -0.0541

Regen BioPharma, Inc. released FY2025 Q3 earnings on August 11 (EST), actual revenue USD 59.07K, actual EPS USD -0.007

Regen BioPharma, Inc. released FY2025 9 Months earnings on August 11 (EST), actual revenue USD 177.2K, actual EPS USD -0.1362

Regen BioPharma, Inc. released FY2025 Semi-Annual Earnings on May 28 (EST), actual revenue USD 118.13K, actual EPS USD -0.0285

Regen BioPharma, Inc. released FY2025 Q2 earnings on May 28 (EST), actual revenue USD 59.07K, actual EPS USD -0.0008

Regen BioPharma, Inc. released FY2025 Q1 earnings on May 16 (EST), actual revenue USD 59.07K, actual EPS USD -0.1253

Regen BioPharma, Inc. released FY2024 Q4 earnings on October 28 (EST), actual revenue USD 59.37 K, actual EPS USD -0.0599

Regen BioPharma, Inc. released FY2024 earnings on October 28 (EST), actual revenue USD 236.56K, actual EPS USD -0.1625

Regen BioPharma, Inc. released FY2024 Q3 earnings on August 13 (EST), actual revenue USD 59.07K, actual EPS USD -0.0308

Regen BioPharma, Inc. released FY2024 9-month earnings on August 13 (EST), actual revenue USD 177.19K, actual EPS USD -0.1009

Regen BioPharma, Inc. released FY2024 Semi-Annual Earnings on April 24 (EST), actual revenue USD 118.13K, actual EPS USD -0.0743

Regen BioPharma, Inc. released FY2024 Q2 earnings on April 24 (EST) with actual revenue of USD 59.06K and EPS of USD -0.0297

Regen BioPharma, Inc. released FY2024 Q1 earnings on January 19 (EST), actual revenue USD 59.07K, actual EPS USD -0.0403

Regen BioPharma, Inc. released its 2023 annual earnings on November 20, with actual revenue of 236.56K USD and EPS of 0.1446

Regen BioPharma, Inc. released Q3 2023 earnings on July 25, 2023, with actual revenue of 177.2K USD and EPS of 0.1842

Regen BioPharma, Inc. released its Semi-annual 2023 earnings on April 18, with actual revenue of 118.13K USD and EPS of 0.2067

Regen BioPharma, Inc. released 1st Q 2023 earnings on January 19, actual revenue 59.07K USD, actual EPS 0.2155

Regen BioPharma, Inc. released its 2022 annual earnings on November 15, with actual revenue of 235.52K USD and EPS of 0.355

Regen BioPharma, Inc. released Q3 2022 earnings on July 22, actual revenue 176.15K USD, actual EPS 0.9612

EVOLUTION METALS & TECHNOLOGIES CORP

Alumis

Sky Quarry

Autozi Internet Tech Global

Envirotech Vehicles

Murano Global BV

Cyclerion Therapeutics

STARRY SEA ACQUISITION CORP COM USD0.0001 (S/R 07/07/2030)

Opendoor Tech Series Z - CW26

Aeva Tech

ADMA生物制药

Kiniksa Pharmaceuticals

Stoke Therapeutics

Rigel制药

OpGen

福泰制药

再生元制药

阿里拉姆制药

Argenx

百济神州

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

Regen BioPharma, Inc.(RGBP.US)